Novartis FCPA Enforcement Action: Fines, Penalties and the Cost of Recidivism
Tom Fox reviews the FCPA enforcement action involving Swiss pharmaceutical company Novartis, its Greek subsidiary, and Alcon Pte Ltd., which combined agreed to pay some $347 million in fines to resolve claims by the DOJ and SEC regarding FCPA violations.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year